About SYNLAB
SYNLAB is a publicly listed company based in Munchen (Germany) founded in 1998, and was acquired by Cinven in June 2015. Provider of medical diagnosis and clinical laboratory analysis services. The company has 28,693 employees. SYNLAB has completed 11 acquisitions, including Belluno Medica, Cityterveys and Igea Sant Antimo. Its chief executive, as recorded, is Mathieu Floreani. Its website synlab.com draws about 144 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is SYNLAB International GmbH.
Company details
SYNLAB was founded in 1998 and is headquartered in Munich, Germany. Operations are conducted in the medical diagnostics sector, with a focus on clinical laboratory analysis. Services encompass various diagnostic categories through an advanced network spanning Europe and beyond. A workforce of over 28,000 employees, including medical experts, supports these activities. The company maintains a global presence to serve customer needs in laboratory testing.
- Headquarters Munchen, Germany
- Employees 28,693
- Stage Public
- SectorsHealthcare
- Website category Health
- Email••••••••
- Phone•••• ••••
- Website synlab.com
- Social LinkedIn X Facebook
- Acquired by Cinven (Jun 2015)
- Legal Name Synlab International Gmbh
- Latest Funding Round$1.8M (USD), Grant
Dec 2016
- InvestorsEuropean Union
& 4 more
- Employee Count28,693
- Investments & AcquisitionsBelluno Medica
& 10 more
- Acquired byCinven
(Jun 2015)
Funding Insights of SYNLAB
- Total Rounds 4
- Last Round Grant — $1.8M
- Investors Count 4
All 4 funding rounds of SYNLAB with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $1.8M | Grant | – | – | |
| Sep 2016 | Grant | – | – | ||
| Feb 2016 | Series A | – | – | ||
| Sep 2009 | Series A | – | – |
5 investors in total: 5 institutional.
Investors in SYNLAB
SYNLAB has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BC Partners and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Diversified alternative assets are managed through investment strategies. | 1986 | bcpartners.com | London, United Kingdom | |
Private equity investments and portfolio management services are provided by Cinven across various sectors. | cinven.com | |||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for SYNLAB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SYNLAB
52 people are tracked at SYNLAB (19 in leadership, 10 in board & advisors, 23 in team); the tracked headcount is 28,693.
| Name | Role | Group |
|---|---|---|
Mathieu Floreani | CEO | Leadership |
Sara Trujillo | Head Of Infrastructure | Leadership |
Sami Badarani | CFO | Leadership |
Gianmarco Greco | Group Head Of Retail | Leadership |
Robert Steinwander | COO | Leadership |
Christoph Mahnke | CEO of SYNLAB Germany | Leadership |
Rainar Aamisepp | CEO of SYNLAB North & East | Leadership |
Antoine Lejeune | COO (operations & Dvpt) Operating Unit North & East @synlab | Leadership |
Andrea Traslaviña | COO Latam | Leadership |
Frederic Bellone | Global Head Of Tax | Leadership |
Andres C. | Chief Financial Officer At Synlab Belgium | Leadership |
Victoria Werner | Head Of Compliance | Leadership |
Asuka A. | Group Head Of ESG | Leadership |
Sylvian Schmid | Group Head Of Technical Services | Medical Technology | Leadership |
Alfredo Alvarez | Head Of Medical Applications | Leadership |
Thorsten Leidermann | Group Head Of Indirect Procurement | Leadership |
Ron Leng | Group Head Of Customer Facing IT | Leadership |
Alexander Hagen | Group Head Of Commercial And Marketing | Leadership |
Luis Alves Martins | Head Of Procurement Excellence | Leadership |
Christian Salling | Supervisory Board Member | Board & advisors |
32 more people are available in the full profile.
Complete people profiles for SYNLAB
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SYNLAB
SYNLAB has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Belluno Medica, Cityterveys and Igea Sant Antimo.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Standalone radiology & pathology laboratory center | igeasantimo.com | Sant Antimo, Italy | 2015 | May 2023 | •••• | |
Standalone general clinic | bellunomedica.it | Belluno, Italy | 2015 | Aug 2022 | •••• | |
Radiology laboratory services are provided in a standalone center. | salusbelluno.it | Belluno, Italy | 1978 | Aug 2022 | •••• | |
X-ray, ultrasound, and diagnostic imaging services are provided. | lmpolanco.com | Mexico | 1977 | Aug 2021 | •••• | |
Biomedical research services for human health are provided. | laboratoriosruiz.com | Puebla, Mexico | 1950 | Aug 2021 | •••• | |
Clinical analysis services are provided with home collection. | labsaojose.pt | Coimbra, Portugal | 1968 | Oct 2019 | •••• | |
Abuse testing, therapeutic drug monitoring, and doping services are provided. | yml.fi | Helsinki, Finland | 2009 | Jul 2018 | •••• | |
| pathcarenigeria.com | 0 | Nov 2017 | •••• | |||
Analytical services for drug, alcohol, and DNA testing are offered. | lextox.co.uk | Cardiff, United Kingdom | 2011 | Aug 2017 | •••• | |
Limited information available | cityterveys.fi | Espoo, Finland | 2014 | Jul 2017 | •••• |
Complete acquisition details for SYNLAB
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SYNLAB
15 dated milestones of SYNLAB across 25 years, from founding to its latest funding, stage changes and deals.
- Founded SYNLAB is founded.
- Funding First funding round.
- Exit Acquired by Cinven.
- Funding Latest funding round, Grant, of $1.8M.
- Acquisition Acquires Cityterveys.
- Acquisition Acquires Lextox.
- Acquisition Acquires Pathcarenigeria.
- Acquisition Acquires Synlab.
- Acquisition Acquires Laboratory S. José.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Laboratorio Medico Polanco.
- Acquisition Acquires Laboratorios Ruiz.
- Acquisition Acquires Salus Belluno.
- Acquisition Acquires Belluno Medica.
- Acquisition Acquires Igea Sant Antimo.
Web traffic of SYNLAB
The website of SYNLAB (synlab.com) receives about 144.5K visits a month and ranks #283,102 among all websites worldwide, #9,723 in Health.
- Monthly visits144.5K
▲ 12.4% vs previous month
- Unique visitors55.3K
per month
- Global rank#283,102
among all websites
- Category rank#9,723
Health · Health
- Bounce rate42%
- Pages per visit2.9
- Average visit1 min 32 sec
- DevicesDesktop 41% · Mobile 59%
Websites whose visitors overlap most with SYNLAB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bioscientia.de | bioscientia.de | 100% | #294,354 | – | |
labor-lademannbogen.de | labor-lademannbogen.de | 99% | – | ||
metuljcica.mojforum.si | metuljcica.mojforum.si | 84% | – | ||
medistar.de | medistar.de | 78% | – | ||
ilbaluardo.it | ilbaluardo.it | 77% | #1,946,733 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for SYNLAB
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synlab
Complete news archive for SYNLAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SYNLAB
SYNLAB was founded in 1998 and raised its 1st funding round 11 years after it was founded.
SYNLAB is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Mathieu Floreani is the CEO of SYNLAB, as recorded in our data.
SYNLAB has 28,693 employees.
SYNLAB was founded in 1998 and is headquartered in Munich, Germany. Operations are conducted in the medical diagnostics sector, with a focus on clinical laboratory analysis. Services encompass various diagnostic categories through an advanced network spanning Europe and beyond. A workforce of over 28,000 employees, including medical experts, supports these activities. The company maintains a global presence to serve customer needs in laboratory testing.
SYNLAB has made 11 acquisitions, including Belluno Medica, Cityterveys, and Igea Sant Antimo.
SYNLAB has 5 investors. Key investors include European Union, BC Partners, EIC Fund, Novo Holdings, and Cinven.
SYNLAB operates through Synlab International Gmbh.
Yes. SYNLAB was acquired by Cinven in June 2015.
The website of SYNLAB receives about 144 thousand visits a month and ranks #283,102 among all websites worldwide.